trazodone has been researched along with amoxapine in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (62.96) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 4 (14.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hietala, J; Kuoppamäki, M; Laakso, A; Majasuo, H; Pälvimäki, EP; Roth, BL; Syvälahti, E | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Manji, HK; Potter, WZ | 1 |
| Brown, TM; Evans, DL; Golden, RN; Miller, H | 1 |
| Hayes, PE; Kristoff, CA | 1 |
| Kulig, K | 1 |
| Gorman, RL; Klein-Schwartz, W; Oderda, GM; Wedin, GP | 1 |
| Blaine, JD; Levine, J; Prien, RF | 1 |
| Mattes, JA | 1 |
| Thompson, TL | 1 |
| Golden, RN; Potter, WZ; Rudorfer, MV | 1 |
| Dominguez, RA | 1 |
| Kane, JM; Lieberman, J | 1 |
| Gold, MS; Lydiard, RB; Pottash, AL | 1 |
| Glassman, AH | 1 |
| Robinson, DS | 1 |
| Gever, LN | 1 |
| Hollister, LE | 1 |
| Settle, EC | 1 |
| Greenblatt, DJ; Shader, RI | 1 |
| Glassman, AH; Preud'homme, XA | 1 |
| Fujimura, Y; Suhara, T | 1 |
| Endo, T; Iwata, M; Kobayashi, H; Nagase, H; Ogawa, N; Ueda, H | 1 |
10 review(s) available for trazodone and amoxapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antidepressants, metabolites, and apparent drug resistance.
Topics: Amoxapine; Antidepressive Agents; Bupropion; Drug Resistance; Humans; Nortriptyline; Propiophenones; Serotonin Antagonists; Trazodone | 1990 |
The new antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Fluoxetine; Maprotiline; Nomifensine; Seizures; Trazodone | 1988 |
Adverse reactions to five new antidepressants.
Topics: Acute Kidney Injury; Amoxapine; Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Dopamine Antagonists; Humans; Male; Maprotiline; Nomifensine; Priapism; Propiophenones; Seizures; Trazodone | 1986 |
Management of poisoning associated with "newer" antidepressant agents.
Topics: Amoxapine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Emergencies; Humans; Maprotiline; Structure-Activity Relationship; Trazodone | 1986 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
The efficacy of amoxapine, maprotiline, and trazodone in comparison to imipramine and amitriptyline: a review of the literature.
Topics: Amitriptyline; Amoxapine; Anthracenes; Clinical Trials as Topic; Depression; Dibenzoxazepines; Humans; Imipramine; Maprotiline; Piperazines; Time Factors; Trazodone | 1984 |
'Second generation' antidepressant drugs.
Topics: Amoxapine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clomipramine; Humans; Maprotiline; Mianserin; Nomifensine; Trazodone; Viloxazine | 1981 |
Review of the cardiovascular effects of heterocyclic antidepressants.
Topics: Amoxapine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Bupropion; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Cardiovascular System; Depressive Disorder; Heart; Humans; Hypotension, Orthostatic; Maprotiline; Selective Serotonin Reuptake Inhibitors; Trazodone | 1993 |
[Biological pathophysiology of mood disorders special reference to the neurotransmitter receptors].
Topics: Amoxapine; Animals; Antidepressive Agents, Second-Generation; Brain; Humans; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Mood Disorders; Nerve Tissue Proteins; Paroxetine; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Receptors, Serotonin, 5-HT2; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Trazodone | 2004 |
4 trial(s) available for trazodone and amoxapine
| Article | Year |
|---|---|
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
Evaluating the effectiveness of the new antidepressants.
Topics: Amoxapine; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Humans; Maprotiline; Trazodone; Trimipramine | 1983 |
The efficacy of amoxapine, maprotiline, and trazodone in comparison to imipramine and amitriptyline: a review of the literature.
Topics: Amitriptyline; Amoxapine; Anthracenes; Clinical Trials as Topic; Depression; Dibenzoxazepines; Humans; Imipramine; Maprotiline; Piperazines; Time Factors; Trazodone | 1984 |
Speed of onset of action of the newer antidepressants.
Topics: Amitriptyline; Amoxapine; Antidepressive Agents; Clinical Trials as Topic; Depression; Depressive Disorder; Double-Blind Method; Humans; Imipramine; Maprotiline; Time Factors; Trazodone | 1984 |
15 other study(ies) available for trazodone and amoxapine
| Article | Year |
|---|---|
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor.
Topics: Animals; Antidepressive Agents, Tricyclic; Choroid Plexus; Citalopram; Fluoxetine; Imipramine; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors | 1996 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Relative toxicity of cyclic antidepressants.
Topics: Adolescent; Adult; Aged; Amoxapine; Anthracenes; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Central Nervous System Diseases; Child; Child, Preschool; Coma; Dibenzoxazepines; Female; Humans; Male; Maprotiline; Maryland; Middle Aged; Poison Control Centers; Retrospective Studies; Seizures; Tachycardia; Trazodone | 1986 |
Antidepressant drug therapy: the role of the new antidepressants.
Topics: Amoxapine; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Depressive Disorder; Drug Evaluation; Humans; Legislation, Drug; Maprotiline; Propiophenones; Trazodone; United States | 1985 |
Side effects of the new antidepressants.
Topics: Amoxapine; Anthracenes; Antidepressive Agents; Dibenzoxazepines; Humans; Maprotiline; Trazodone | 1986 |
Update on some of the older and newer antidepressants.
Topics: Aged; Amoxapine; Antidepressive Agents; Arrhythmias, Cardiac; Humans; Maprotiline; Parasympathetic Nervous System; Sleep Stages; Trazodone | 1985 |
The newer antidepressant drugs and their cardiovascular effects.
Topics: Amoxapine; Antidepressive Agents; Bupropion; Cardiovascular System; Electrocardiography; Humans; Hypotension, Orthostatic; Maprotiline; Myocardial Contraction; Propiophenones; Trazodone | 1984 |
Adverse reactions, toxicities, and drug interactions of newer antidepressants: anticholinergic, sedative, and other side effects.
Topics: Amoxapine; Antidepressive Agents; Bupropion; Drug Interactions; Humans; Hypnotics and Sedatives; Maprotiline; Parasympatholytics; Propiophenones; Trazodone | 1984 |
Three new antidepressants amoxapine, maprotiline, and trazodone.
Topics: Amoxapine; Antidepressive Agents; Depression; Humans; Maprotiline; Trazodone | 1983 |
Recently introduced antidepressants: their place in clinical practice.
Topics: Amoxapine; Antidepressive Agents; Bundle of His; Chemical Phenomena; Chemistry; Depressive Disorder; Electrocardiography; Erythema; Heart Rate; Humans; Maprotiline; Trazodone; Tremor; Trimipramine | 1982 |
Antidepressants: the second harvest and DSM-III.
Topics: Amoxapine; Antidepressive Agents; Depressive Disorder; Humans; Trazodone | 1981 |
Evaluation of the interaction between β-cyclodextrin and psychotropic drugs by surface plasmon resonance assay with a Biacore ® system.
Topics: Amoxapine; beta-Cyclodextrins; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Humans; Kinetics; Models, Chemical; Protein Binding; Psychotropic Drugs; Reproducibility of Results; Solubility; Surface Plasmon Resonance; Trazodone | 2011 |